TomoTherapy Incorporated (NASDAQ: TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, has earned top honors in MD Buyline’s user satisfaction rankings for the second consecutive quarter, solidifying its position as the customer service leader in linear accelerator-based radiation therapy. Read the full story at http://ca.prweb.com/releases/tomotherapy/md_buyline/prweb1072684.htm